Gargling to wash the throat is commonly performed in Japan, and people believe that such hygienic routine, especially with gargle medicine, prevents upper respiratory tract infections (URTIs). Its effectiveness, however, has not been established by clinical trials.
Randomized controlled trial carried out in 2002–2003 winter season and analyzed in 2003 and 2004.
Healthy volunteers (387) aged 18 to 65 years.
Participants were randomly assigned to water gargling, povidone-iodine gargling, and usual care (control). Subjects in the two gargling groups were requested to gargle with water or diluted povidone-iodine at least three times a day. Participants were followed for 60 days.
Main Outcome Measures
The primary outcome measure was first URTI incidence. Severity of URTI symptoms among incident cases was also evaluated. Both outcomes were assessed with a self-administered symptom record. Analyses were performed on an intention-to-treat basis.
A total of 130 participants contracted URTIs. The incidence rate of first URTI was 0.26 episodes/30 person-days among control subjects. The rate decreased to 0.17 episodes/30 person-days in the water gargling group, and 0.24 episodes/30 person-days in the povidone-iodine gargling group. Respective incidence rate ratios against controls were 0.64 (95% confidence interval [CI]=0.41–0.99) and 0.89 (95% CI=0.60–1.33). A Cox regression (proportional hazard model) revealed the efficacy of water gargling (hazard ratio=0.60, 95% CI=0.39–0.95). Even when a URTI occurred, water gargling tended to attenuate bronchial symptoms (p=0.055).
Simple water gargling was effective to prevent URTIs among healthy people. This virtually cost-free modality would appreciably benefit the general population.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Preventive Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The economic burden of non-influenza-related viral respiratory tract infection in the United States.Arch Intern Med. 2003; 163: 487-494
- Acute respiratory illness in an American community.JAMA. 1974; 227: 164-169
- Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine.Antiviral Res. 2002; 54: 89-97
- Inactivation of human viruses by povidone-iodine in comparison with other antiseptics.Dermatology. 1997; 195: 29-35
- A questionnaire survey to evaluate the efficiency of gargling.San Ei Shi. 1996; 38 (in Japanese): 217-222
- Effects of gargling on the epidemic of influenza. 1987; 35 (Abstracts of the 35th meeting of the Japanese Society of Virology (in Japanese)): 292
- Prevention of respiratory infections by povidone-iodine gargle.Dermatology. 2002; 204: 32-36
- Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations.Dermatology. 2002; 204: 37-41
- Transmission of the common cold to volunteers under controlled conditions.Arch Intern Med. 1958; 101: 267-278
- Clinical significance and pathogenesis of viral respiratory infections.Am J Med. 2002; 112: 13S-18S
- Review.J Struct Biol. 1999; 128: 69-74
- Species-specific receptor recognition by a minor-group human rhinovirus (HRV).J Virol. 2002; 76: 6957-6965
- Effects of chlorine, iodine, and quaternary ammonium compound disinfectants on several exotic disease viruses.J Vet Med Sci. 2000; 62: 85-92
- Chlorine inactivation of adenovirus type 40 and feline calicivirus.Appl Environ Microbiol. 2003; 69: 3979-3985
- Potential use of nonpathogenic enteroviruses for control of human disease.Prog Med Virol. 1989; 36: 191-202
- Viral infections of the oral mucosa in children.Pract Periodontics Aesthet Dent. 1997; 9: 683-690
- Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces.Expert Opin Invest Drugs. 2000; 9: 1711-1721
- Dilute povidone-iodine solutions inhibit human skin fibroblast growth.Dermatol Surg. 2002; 28: 210-214
- The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora.Dermatology. 2002; 204: 70-74
- Protective effect of topical iodine preparations upon heat-induced and hydrofluoric acid-induced skin lesions.Toxicol Pathol. 2002; 30: 552-558
- Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents.Dermatology. 1997; 195: 89-92
- Effect of povidone-iodine on wound healing.J Vasc Nurs. 1999; 17: 17-23
- Povidone-iodine solution in wound treatment.Phys Ther. 1998; 78: 212-218
- Povidone-iodine as a topical antiseptic for treating and preventing wound infection.Br J Community Nurs. 2003; 8: S36-S42
© 2005 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.